---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295550944.md"
description: "Alamar Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results. Also, JP Morgan maintained its Overweight rating on the stock and raised its price target from $32 to $35."
datetime: "2026-08-11T14:23:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295550944.md)
  - [en](https://longbridge.com/en/news/295550944.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295550944.md)
---

# 

Alamar Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results. Also, JP Morgan maintained its Overweight rating on the stock and raised its price target from $32 to $35.

### Related Stocks

- [ALMR.US](https://longbridge.com/en/quote/ALMR.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)

## Related News & Research

- [Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum](https://longbridge.com/en/news/295565203.md)
- [Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure](https://longbridge.com/en/news/295628996.md)
- [Frank M. Sands discloses investment in Alamar Biosciences with 6.3% stake](https://longbridge.com/en/news/283876475.md)
- [Top 3 Health Care Stocks That May Implode In August](https://longbridge.com/en/news/295669555.md)
- [Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH](https://longbridge.com/en/news/295629545.md)